Table:
begin	end	state
1	27	signal peptide
28	257	non-cytoplasmic
258	282	transmembrane
283	284	cytoplasmic
285	305	transmembrane
306	310	non-cytoplasmic
311	334	transmembrane
335	345	cytoplasmic
346	364	transmembrane
365	397	non-cytoplasmic
398	415	transmembrane
416	443	cytoplasmic
444	464	transmembrane
465	480	non-cytoplasmic
481	505	transmembrane
506	512	cytoplasmic
513	531	transmembrane
532	548	non-cytoplasmic

Input:
>WP_019864733.1 NCBI__GCF_000384075.1:WP_019864733.1
MTLFNPTRCQALLALLMLVFSLAAHSDPQPAPQPWLDALDTLKQGSMPEREKAIMQLADI
KDAHNLAILQALLDSKLFITKTDARLVIGTDNHQGFDLSDAVSGASLGAVGHDALTKINL
TNKMRGTLRKIIGELELSADDPKVRLAAVKAMAKEADEKAISLLRERAGQEQDEAVREAI
KVALLLQDMDSEDKAVRIMAIEGLKAYDSQEAANRLNAMLEKDENGEYSEPDADVRNLAK
ASLTNINNRLQLYGSIETIFFGLSLGAVLVLSAIGLAITFGVMGVINMAHGELMMLGAYT
TYVIQQLMPNYLGVSVIIAIPAAFVISALAGIAIERGIIRFLYGRPLETLLATFGVSLIL
QQSVRSIFSPLNRSVATPEWMSGSWQINDFLSLTWNRFYILVFCLLVFVLLLQILKRTSL
GLEVRAVAQNRKMAKAMGIPTARVDAMTFGLGSGIAGVAGVALSQITNVGPNLGQAYIVD
SFMVVVFGGVGNLLGTLVAGFSLGIANKFLEPFAGAVLAKILVLVFIILFIQKRPRGLFP
QKGRAADS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server